NAMP
SLS icon

NorthStar Asset Management (Pennsylvania)’s SELLAS Life Sciences SLS Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Sell
45,000
-5,000
-10% -$34.5K 0.1% 102
2026
Q1 		$212K Hold
50,000
– – 0.05% 133
2025
Q4 		$189K Buy
50,000
+9,680
+24% +$18.8K 0.04% 135
2025
Q3 		$64.9K Buy
+40,320
New +$71.8K 0.01% 141

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NorthStar Asset Management (Pennsylvania)'s SLS Position: Q2 2026 in Review

NorthStar Asset Management (Pennsylvania) reduced its SELLAS Life Sciences (SLS) stake by 10% in Q2 2026, selling an estimated $34.5K and leaving 45,000 shares worth $509K. The position accounts for 0.1% of the portfolio, ranked #102.

NorthStar Asset Management (Pennsylvania) first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • NorthStar Asset Management (Pennsylvania) held 45,000 shares of SELLAS Life Sciences worth $509K as of Q2 2026.
  • NorthStar Asset Management (Pennsylvania) sold 5,000 SELLAS Life Sciences shares in Q2 2026, an estimated $34.5K.
  • SELLAS Life Sciences made up 0.1% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q2 2026, its #102 holding.
  • NorthStar Asset Management (Pennsylvania) first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q2 2026, filed 27 Jul 2026.